Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review
MT Long, M Noureddin, JK Lim - Gastroenterology, 2022 - Elsevier
Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the
global population; its burden has grown in parallel with rising rates of type 2 diabetes …
global population; its burden has grown in parallel with rising rates of type 2 diabetes …
Non-alcoholic fatty liver disease: Definition and subtypes
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …
worldwide, with a global prevalence of approximately 30%. However, the prevalence of …
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Metabolic dysfunction–associated steatohepatitis (MASH) is a severe form of liver disease
that poses a global health threat because of its potential to progress to advanced fibrosis …
that poses a global health threat because of its potential to progress to advanced fibrosis …
the epidemiologic burden of non‐alcoholic fatty liver disease across the world
Background The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing in
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
parallel with obesity and type 2 diabetes. Aim To review the global epidemiology of NAFLD …
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Background Although non-alcoholic fatty liver disease (NAFLD) is commonly associated
with obesity, it is increasingly being identified in non-obese individuals. We aimed to …
with obesity, it is increasingly being identified in non-obese individuals. We aimed to …
[HTML][HTML] Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
Background & Aims Biopsy-confirmed liver fibrosis is a prognostic factor for patients with
nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the …
nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the …
[HTML][HTML] Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors
Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of chronic liver
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …
disease in the Western world, probably due to the growing prevalence of obesity, metabolic …
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Objective Population-based data are lacking regarding the risk of overall and cause-specific
mortality across the complete histological spectrum of non-alcoholic fatty liver disease …
mortality across the complete histological spectrum of non-alcoholic fatty liver disease …
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Fatty liver associated with metabolic dysfunction is common, affects a quarter of the
population, and has no approved drug therapy. Although pharmacotherapies are in …
population, and has no approved drug therapy. Although pharmacotherapies are in …